Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
320
Trial Sponsor
Clinical Trial Start Date
2013
0Primary Completion Date
2013
0Study Completion Date
2013
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Basic Science0
Intervention Type
Drug0
Interventional Trial Phase
Phase 10
Official Name
An Open-Label, Single-Dose Trial to Assess the Effects of Hepatic Impairment on the Pharmacokinetics of Obeticholic Acid (OCA)0
Last Updated
October 24, 2013
0Allocation Type
Non-Randomized0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Other attributes
Intervention Treatment
obeticholic acid 10 mg0
Study summary
This is a phase 1 study to evaluate the safety of a single 10 mg dose of obeticholic acid (OCA) in healthy volunteers and patients with liver disease.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
